Nasdaq
$70.88▲ 0.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.45BShares out 34.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 9.29After-hours26.09.30 05:153Ownership#●●●
TransMedics Group, Inc.
Fernando Araujo, an officer of TransMedics Group, has executed a limited power of attorney. This document authorizes Waleed Hassanein and Matthew Forsyth to prepare and file SEC reports, including Forms 3, 4, 5, and Schedules 13D or 13G, on his behalf.…more
$70.88+0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.14After-hours26.09.15 05:304Ownership
TransMedics Group, Inc.
Insider David Weill of TransMedics Group, Inc. filed a Form 4 report on September 14, 2026, regarding changes in beneficial ownership of securities as of September 11, 2026.…more
$70.88+0.23%vs prev closeView filingShare - 9.10After-hours26.09.11 05:408-KKey event
TransMedics Group, Inc.
TransMedics Group, Inc. announced the appointment of Fernando Araujo as the new CFO, effective September 21, 2026, while the outgoing CFO, Gerardo Hernandez, will transition to a strategic advisory role for Latin American expansion. The company also reiterated its full-year 2026 revenue guidance of $737 million to $757 million.…more
$70.88+0.23%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.10After-hours26.09.11 05:14#●●●#●●●
TransMedics Appoints New CFO and Reaffirms 2026 Revenue Guidance
TransMedics has appointed Fernando Araujo as its new CFO and reaffirmed its 2026 full-year revenue guidance of $737 million to $757 million. This outlook represents a 22% to 25% year-over-year growth and will be reviewed during the company's third-quarter earnings report.…more
$70.88+0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga